Department of Radiation Oncology

James M. Metz

faculty photo

James M. Metz, M.D.

Henry K. Pancoast Professor of Radiation Oncology
Department: Radiation Oncology

Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
2 West
Philadelphia, PA 19104
Office: 2156622428
Fax: 215-349-5445
Education:
BS (Biology)
Juniata College , 1989.
MS (Clinical Immunology/Microbiology)
Hahnemann University , 1991.
MD (Medicine)
UMDNJ-Robert Wood Johnson Med School, 1995.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Dr. Metz serves as Chair of Radiation Oncology at the Perelman School of Medicine and holds the Henry K. Pancoast Endowed Professorship. He is Associate Director for Clinical Services and Programs at the Abramson Comprehensive Cancer Center of the University of Pennsylvania. Dr. Metz led the development of the Roberts Proton Therapy Center, the largest proton center in the world completely integrated with conventional cancer services. Dr. Metz has become an international leader in the application of proton therapy for the treatment of a variety of malignancies. He continues to work to integrate proton therapy as a new treatment paradigm for cancer and is leading the expansion of proton therapy.

Dr. Metz specializes in the use of radiation for the treatment of gastrointestinal malignancies. His research interests include the treatment of GI malignancies in the multidisciplinary setting, as well as the utilization of complementary and alternative medications by cancer patients, and use of the Internet to provide cancer related information. A major area of interest has been the development of proton therapy at Penn and internationally.

Dr. Metz also serves as Executive Director of OncoLink (www.oncolink.upenn.edu), the award winning Internet resource from the Abramson Comprehensive Cancer Center of the University of Pennsylvania that was founded in 1994. As Executive Director, Dr. Metz leads OncoLink’s mission to help cancer patients, families, health care professionals, and the general public find accurate cancer-related information online. The website has led the way in online education for cancer patients and healthcare providers, receiving numerous awards and recognition from most major authorities as one of the best cancer information websites. Currently OncoLink is developing interactive content and personalized information for individuals while collecting important information to move the field forward, particularly in the area of cancer survivorship. Its reach is international in scope with over 285,000 unique visitors served per month.

Selected Publications

Szalda D1,2, Schapira MM3, Jacobs LA1, Palmer SC1, Vachani C4, Metz J4, Hill-Kayser C2,4. : Survivorship Care Planning for Young Adults After Cancer Treatment:Preliminary Understanding Care Patterns and Patient-Reported Outcomes. J Adolesc Young Adult Oncol. 7(4): 430-437, Aug 2018.

Benci JL1, Vachani CC1, Bach C1, Arnold-Korzeniowski K1, Hampshire MK1, Metz JM1, Hill-Kayser CE2. : Identifying barriers to cancer survivors sharing their survivorship care plans with their healthcare provider. J Cancer Surviv. Jul 3. 2018.

Frick M, Vachani C, Bach C, Arnold-Korzienowski K, Hampshire M, Metz JM, Hill-Kayser CE: Patient-Reports of Fatigue and Cognitive Changes in Cancer Survivors. Gerontology & Geriatric Medicine 4(1): 1-5, May 2018.

Baumann BC1,2,3, Wei J4, Plastaras JP1, Lukens JN1, Damjanov N5, Hoteit M6, Hsu C6, Levine M7, Mondschein J8, Nadolski G8, Olthoff K7, Reiss KA5, Rosen M9, Siegelman E9, Metz JM1, Ben-Josef E1. : Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low Toxicity. Am J Clin Oncol. March 16 2018.

Guttmann DM, Mitra N, Metz JM, Plastaras J, Feng W, Swisher-McClure S. : Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer. J Geriatr Oncol. 9(1): 40-46, Jan 2018.

Boimel PJ, Berman AT, Li J, Apisarnthanarax S, Both S, Lelionis1 K, Larson GL, Teitelbaum U, Lukens JN, Ben-Josef E, Metz JM, Plastaras JP : Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma Journal of Gastrointestinal Oncology 2017 Notes: in press.

Baumann BC, Zeng C, Freedman GM, Verginadis II, MacArthur KM, Lin LL, Vachani C, Koumenis C, Solberg TD, Metz JM : Avoiding antiperspirants during breast radiation therapy: Myth or sound advice? Radiother Oncol 2017.

Frick MA, Vachani CC, Bach C, Hampshire MK, Arnold-Korzeniowski K, Metz JM, Hill-Kayser CE : Survivorship and the chronic cancer patient: Patterns in treatment-related effects, follow-up care, and use of survivorship care plans. Cancer 2017.

Frick MA, Vachani CC, Hampshire MK, Bach C, Arnold-Korzeniowski K, Metz JM, Hill-Kayser CE. : Survivorship after lower gastrointestinal cancer: Patient-reported outcomes and planning for care. Cancer 2017.

Guttmann DM, Mitra N, Bekelman J, Metz JM, Plastaras J, Feng W, Swisher-McClure S: Improved overall survival with aggressive primary tumor radiotherapy for patients with metastatic esophageal cancer Journal of Thoracic Oncology 2017 Notes: in press.

back to top
Last updated: 09/20/2018
The Trustees of the University of Pennsylvania
 
Top

© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.